Stock Price
1.29
Daily Change
-0.11 -7.86%
Monthly
-23.67%
Yearly
1.57%
Q2 Forecast
1.26

Geron reported $121.99M in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
Amgen USD 54.6B 17M Dec/2025
Bio Techne USD 200M 60M Mar/2026
Cassava Sciences USD 0 0 Dec/2024
Cytokinetics USD 1.29B 4.48M Mar/2026
Esperion Therapeutics USD 262.92M 1.76M Sep/2024
Exelixis USD 169.54M 3.5M Mar/2026
Genmab DKK 148M 5M Jun/2025
Geron USD 121.99M 76K Dec/2025
Gilead Sciences USD 24.94B 5M Dec/2025
Incyte USD 39.43M 982K Mar/2026
MacroGenics USD 37.01M 238K Sep/2025
Novartis USD 47B 11.62B Mar/2026
Novavax USD 233.31M 4.23M Sep/2024